Clinical Trial Update: Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study of eltrombopag in Japanese patients with thrombocytopenia due to chronic liver disease; the study has completed and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Liver Diseases | Phase 2 | Status: COMPLETED | Results posted: 2010-09-23